neferine has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, R; Griffin, BB; Kong, B; Li, Y; Liu, Z; Miao, C; Wang, Y; Xu, Y; Yan, S; Yang, X; Yuan, C; Zhang, Q; Zhang, Z | 1 |
| Li, J; Li, Y; Liu, Z; Lu, S; Shao, C; Tian, X; Wang, Y; Wei, JJ; Xu, L; Zhang, X | 1 |
2 other study(ies) available for neferine and Ovarian Neoplasms
| Article | Year |
|---|---|
Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Autophagy; Benzylisoquinolines; Cell Cycle; Cell Movement; Cell Proliferation; Cystadenocarcinoma, Serous; Female; Humans; Macrophages; Mice; Neoplasm Grading; Neovascularization, Pathologic; Ovarian Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Neferine induces autophagy of human ovarian cancer cells via p38 MAPK/ JNK activation.
Topics: Antineoplastic Agents; Autophagy; Benzylisoquinolines; Cell Line, Tumor; Female; Humans; MAP Kinase Signaling System; Nelumbo; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Plant Extracts; TOR Serine-Threonine Kinases | 2016 |